Uncomplicated and complicated UTI’s are commonly encountered in primary care and emergency settings. Using a case study approach, this session will focus on the management of a UTI’s in the following: the older individual, the person with an indwelling catheter or a structural abnormality, and those with pyelonephritis. In addition, a discussion regarding antimicrobial resistance and its impact on treating the complicated and uncomplicated UTI will be offered. | 1.5 CE/CME category 1 credits (1.50 Pharmacology) | $45

Since electronic nicotine delivery systems or ENDs (e-cigarettes), came to the US market in 2006, their use has increased exponentially, especially in the adolescents along with a proliferation and evolution of devices. Use of ENDs in adolescents has exposed them to nicotine containing tobacco products and well as other substances. There has been some evidence that e-Cigarettes may have some efficacy as a harm reduction tool in certain long term combustible tobacco users, the identification of serious known and potential harms are increasing. We will discuss the evolution of these products, current trends in use, known and potential harms, their potential as harm reduction tool, and their overall impact on public health, and changes in health policies. | 1.0 CE/CME category 1 credits (1.00 Pharmacology) | $30

This session reviews the diagnosis and management of alcohol-associated liver disease, providing clinicians with practical guidance for both outpatient and inpatient care. Participants will learn to recognize the clinical spectrum of disease, from early steatosis to alcoholic hepatitis and cirrhosis. The session will also cover common complications of liver disease and outline evidence-based treatment strategies, including medical management, supportive care, and referral considerations. | 1.0 CE/CME category 1 credits (0.50 Pharmacology) | $30

Understand negative effects of stress, define extreme self-care, and describe the benefits of being a healthy role model. Discuss strategies for lifelong prevention/management of stress. Learn how to break unhealthy habits and how to create healthy habits and how to sustain these new healthy habits over time. | 1.0 CE/CME category 1 credits (0.0 Pharmacology) | $10

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders affecting females and has significant reproductive, metabolic, and psychosocial implications that extend far beyond adolescence. This evidence-based presentation explores the evolving clinical manifestations of PCOS across the lifespan, from early recognition in adolescents to long-term management in adulthood. Participants will review the epidemiology and pathophysiology of PCOS, current diagnostic criteria, and common differential diagnoses while examining associated comorbidities, including infertility, insulin resistance, obesity, type 2 diabetes, cardiovascular risk, and mental health disorders. | 1.5 CE/CME category 1 credits (1.00 Pharmacology) | $35

This session will focus on pharmacologic strategies to retard progression of chronic kidney disease (RAS blockade, GLP-1 analogues, SGLT-2 inhibitors, and non-steroidal mineralocorticoid antagonists) as well as treatment of chronic kidney disease complications such as hyperkalemia, chronic kidney disease associated pruritus, and anemia. Since cardiovascular disease is the leading cause of death in patients with chronic kidney disease, this session will also focus on the interplay between chronic kidney disease and cardiovascular disease and pharmacologic and non-pharmacologic interventions to reduce the risk of adverse cardiovascular events in this patient population. | 1.5 CE/CME category 1 credits (1.00 Pharmacology) | $35

This session discusses many types of pain that can be musculoskeletal but could also be something more serious, when NOT to miss a life threatening diagnosis. | 1.5 CE/CME category 1 credits (0.25 Pharmacology) | $35

This presentation will cover normal female sexual development, common myths and misperceptions about female sexual health, common female sexual health concerns and female sexual problem management. | 3.0 CE/CME category 1 credits (2.00 Pharmacology) | $70

This session discusses the diagnosis and treatment of hypogonadism and testosterone replacement. What we can and cannot give and what the latest data tells us. | 1.0 CE/CME category 1 credits (1.00 Pharmacology) | $30

Selecting the appropriate anticoagulant for patients with atrial fibrillation (AF) requires more than simply choosing a medication. Clinicians must balance stroke prevention with bleeding risk while considering patient-specific factors such as age, renal function, comorbidities, drug interactions, adherence, and cost. This engaging, evidence-based session will review current guideline recommendations for anticoagulation in non-valvular atrial fibrillation and provide practical strategies for selecting and managing anticoagulant therapy in primary care. | 1.5 CE/CME category 1 credits (1.50 Pharmacology) | $40